{"id":"methylprednisolone-mp","safety":{"commonSideEffects":[{"rate":null,"effect":"Hyperglycemia"},{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Insomnia and mood disturbances"},{"rate":null,"effect":"Immunosuppression and increased infection risk"},{"rate":null,"effect":"Osteoporosis (with chronic use)"},{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Cushingoid features (with prolonged use)"}]},"_chembl":{"chemblId":"CHEMBL1697782","moleculeType":"Small molecule","molecularWeight":"472.58"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Methylprednisolone acts as a potent immunosuppressant and anti-inflammatory agent by activating intracellular glucocorticoid receptors, which translocate to the nucleus and modulate gene expression. This leads to decreased production of inflammatory mediators (cytokines, chemokines, adhesion molecules) and reduced immune cell activation and proliferation. It is commonly used in high-dose regimens for acute inflammatory and autoimmune conditions, as well as in lower maintenance doses for chronic disease management.","oneSentence":"Methylprednisolone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:49.799Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute inflammatory and autoimmune conditions (e.g., lupus, vasculitis, multiple sclerosis exacerbations)"},{"name":"Lymphoma and leukemia (as adjunctive therapy in chemotherapy regimens)"},{"name":"Graft-versus-host disease (GVHD) prophylaxis and treatment"},{"name":"Cerebral edema associated with malignancy or trauma"},{"name":"Rheumatoid arthritis and other rheumatologic disorders"}]},"trialDetails":[{"nctId":"NCT06317662","phase":"PHASE2","title":"Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-06-05","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia","enrollment":153},{"nctId":"NCT03914625","phase":"PHASE3","title":"A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-03","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome","enrollment":6720},{"nctId":"NCT06124157","phase":"PHASE3","title":"A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-05-30","conditions":"B Acute Lymphoblastic Leukemia","enrollment":222},{"nctId":"NCT03959085","phase":"PHASE3","title":"Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2019-10-31","conditions":"B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Central Nervous System Leukemia","enrollment":5951},{"nctId":"NCT04216524","phase":"PHASE2","title":"Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-05-29","conditions":"Blastic Plasmacytoid Dendritic Cell Neoplasm","enrollment":40},{"nctId":"NCT03007147","phase":"PHASE3","title":"Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-08-08","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":475},{"nctId":"NCT03579875","phase":"PHASE2","title":"Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2018-11-13","conditions":"Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes","enrollment":48},{"nctId":"NCT07317596","phase":"PHASE3","title":"Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications","status":"ENROLLING_BY_INVITATION","sponsor":"Sana'a University","startDate":"2024-06-27","conditions":"Wisdom Tooth Removal, Post Operative Complications, Hyaluronic Acid","enrollment":40},{"nctId":"NCT07328906","phase":"NA","title":"Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome","status":"NOT_YET_RECRUITING","sponsor":"University of Belgrade","startDate":"2026-01","conditions":"Postimplantation Syndrome, Myocardial Injury, MACE","enrollment":174},{"nctId":"NCT07072585","phase":"PHASE2, PHASE3","title":"Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)","status":"NOT_YET_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2026-06-28","conditions":"Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma, Stage IV T Lymphoblastic Leukemia/Lymphoma","enrollment":1708},{"nctId":"NCT07175623","phase":"NA","title":"Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2025-09-16","conditions":"Neuromuscular Block, Residual, Pain Management, Postoperative Nausea","enrollment":60},{"nctId":"NCT03117751","phase":"PHASE2, PHASE3","title":"Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2017-03-29","conditions":"Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma","enrollment":790},{"nctId":"NCT07187037","phase":"NA","title":"Methylprednisolone vs Dexamethasone: Effects on Sugammadex Reversal, Pain, and Nausea in Adults","status":"NOT_YET_RECRUITING","sponsor":"Konya City Hospital","startDate":"2025-10-01","conditions":"Neuromuscular Block, Residual, Pain, Postoperative Nausea","enrollment":130},{"nctId":"NCT07180277","phase":"PHASE4","title":"Methylprednisolone for Moderate to Severe Traumatic Brain Injury","status":"NOT_YET_RECRUITING","sponsor":"Zhangjiagang First People's Hospital","startDate":"2025-10-01","conditions":"Traumatic Brain Injury","enrollment":520},{"nctId":"NCT06199557","phase":"PHASE1, PHASE2","title":"A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients","status":"RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2024-05-23","conditions":"Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes, Adult","enrollment":48},{"nctId":"NCT06474273","phase":"PHASE3","title":"TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients","status":"NOT_YET_RECRUITING","sponsor":"University of Sydney","startDate":"2025-06","conditions":"Rejection; Transplant, Kidney, Rejection; Transplant, Pancreas","enrollment":540},{"nctId":"NCT02205762","phase":"PHASE2, PHASE3","title":"LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"North American Consortium for Histiocytosis","startDate":"2016-11-02","conditions":"Langerhans Cell Histiocytosis","enrollment":1400},{"nctId":"NCT03643276","phase":"PHASE3","title":"Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017","status":"RECRUITING","sponsor":"Martin Schrappe","startDate":"2018-07-15","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":5000},{"nctId":"NCT02828358","phase":"PHASE2","title":"Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-04-01","conditions":"Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":78},{"nctId":"NCT06802432","phase":"EARLY_PHASE1","title":"Corticosteroids Prevent the Atrial Fibrillation After Cardiac Surgery","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Post Operative Arrythmia, Anesthesia, Cardiac Surgery","enrollment":84},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT00557193","phase":"PHASE3","title":"Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-01-15","conditions":"Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia","enrollment":218},{"nctId":"NCT06457464","phase":"","title":"Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2024-07-01","conditions":"Multiple Myeloma","enrollment":100},{"nctId":"NCT04832269","phase":"","title":"Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2020-10-19","conditions":"Multiple Sclerosis","enrollment":80},{"nctId":"NCT05666336","phase":"PHASE4","title":"Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients","status":"UNKNOWN","sponsor":"Fen Li","startDate":"2022-12-31","conditions":"Systemic Lupus Erythematosus","enrollment":30},{"nctId":"NCT03286634","phase":"PHASE2","title":"ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016","status":"RECRUITING","sponsor":"National Hospital Organization Nagoya Medical Center","startDate":"2017-04-18","conditions":"Down Syndrome, Acute Lymphoblastic Leukemia, Childhood Cancer","enrollment":60},{"nctId":"NCT00549848","phase":"PHASE3","title":"Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2007-10-29","conditions":"Acute Lymphoblastic Leukemia","enrollment":600},{"nctId":"NCT04876534","phase":"PHASE2","title":"Tocilizumab in Active Moderate-severe Graves' Orbitopathy","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2019-12-18","conditions":"Graves Ophthalmopathy","enrollment":64},{"nctId":"NCT01451515","phase":"PHASE2","title":"NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2012-05-25","conditions":"Lymphoblastic Lymphoma","enrollment":23},{"nctId":"NCT04673162","phase":"PHASE3","title":"Evaluation of the Efficacy of High Doses of Methylprednisolone in SARS-CoV2 ( COVID-19) Pneumonia Patients","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2020-12-17","conditions":"Covid19","enrollment":260},{"nctId":"NCT04636671","phase":"PHASE3","title":"Methylprednisolone vs. Dexamethasone in COVID-19 Pneumonia (MEDEAS RCT)","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2021-04-14","conditions":"Covid19, Viral Pneumonia Human Coronavirus, Severe Acute Respiratory Syndrome","enrollment":690},{"nctId":"NCT01085097","phase":"PHASE2","title":"A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2010-09-01","conditions":"Lupus Nephritis","enrollment":46},{"nctId":"NCT03466801","phase":"NA","title":"The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.","status":"TERMINATED","sponsor":"Wenhu Liu","startDate":"2018-03-20","conditions":"Idiopathic Membranous Nephropathy","enrollment":6},{"nctId":"NCT03636165","phase":"PHASE4","title":"Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Post-Craniotomy Pain in Children","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2022-09-01","conditions":"Pain, Postoperative, Post-Craniotomy Headache","enrollment":90},{"nctId":"NCT00630253","phase":"PHASE1, PHASE2","title":"Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2000-02-17","conditions":"Fanconi Anemia","enrollment":31},{"nctId":"NCT02472054","phase":"PHASE1, PHASE2","title":"Treatment of Familiar Lymphohistiocytosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-06-29","conditions":"Hemophagocytic Lymphohistiocytosis (HLH)","enrollment":29},{"nctId":"NCT04078139","phase":"PHASE4","title":"Pre-emptive Scalp Infiltration With Methylprednisolone Plus Ropivacaine for Postoperative Pain After Craniotomy","status":"UNKNOWN","sponsor":"Beijing Tiantan Hospital","startDate":"2021-03-05","conditions":"Pain, Postoperative","enrollment":188},{"nctId":"NCT04509219","phase":"PHASE1","title":"Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2020-04-15","conditions":"Mucocutaneous Lymph Node Syndrome","enrollment":10},{"nctId":"NCT04323592","phase":"","title":"Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome","status":"COMPLETED","sponsor":"University of Trieste","startDate":"2020-03-23","conditions":"Severe Acute Respiratory Syndrome (SARS) Pneumonia, Coronavirus Infections, ARDS, Human","enrollment":173},{"nctId":"NCT04273321","phase":"NA","title":"Efficacy and Safety of Corticosteroids in COVID-19","status":"COMPLETED","sponsor":"Beijing Chao Yang Hospital","startDate":"2020-02-14","conditions":"COVID-19, Novel Coronavirus Pneumonia","enrollment":86},{"nctId":"NCT00720109","phase":"PHASE2, PHASE3","title":"Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-07-14","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":63},{"nctId":"NCT04192656","phase":"PHASE4","title":"The Effect of PAP on ISSHL Comorbided With OSA","status":"RECRUITING","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2019-11-01","conditions":"Sudden Hearing Loss, Obstructive Sleep Apnea","enrollment":102},{"nctId":"NCT00657059","phase":"PHASE3","title":"Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2007-09","conditions":"IgA Nephropathy","enrollment":151},{"nctId":"NCT00004228","phase":"PHASE3","title":"Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-06","conditions":"Lymphoma","enrollment":393},{"nctId":"NCT00561067","phase":"PHASE3","title":"Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)","status":"TERMINATED","sponsor":"Niguarda Hospital","startDate":"2008-04","conditions":"Spinal Cord Injury","enrollment":10},{"nctId":"NCT01049451","phase":"PHASE1","title":"Pulse ACTH vs. MP for MS","status":"COMPLETED","sponsor":"University of Southern California","startDate":"2009-11","conditions":"Multiple Sclerosis","enrollment":23},{"nctId":"NCT00376077","phase":"PHASE3","title":"A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2005-08","conditions":"Immune Thrombocytopenic Purpura","enrollment":32},{"nctId":"NCT02339142","phase":"PHASE4","title":"Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2015-01","conditions":"Graves Ophthalmopathy","enrollment":100},{"nctId":"NCT00015873","phase":"PHASE3","title":"Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Dutch Childhood Oncology Group","startDate":"1999-05","conditions":"Leukemia","enrollment":350},{"nctId":"NCT01969019","phase":"PHASE4","title":"A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2010-01","conditions":"Graves' Ophthalmopathy","enrollment":70},{"nctId":"NCT00934154","phase":"PHASE3","title":"Melphalan+Prednisolon With or Without Thalidomide in Previously Untreated Elderly Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Cigdem Sahinbas YILMAZ","startDate":"2006-03","conditions":"Multiple Myeloma","enrollment":122},{"nctId":"NCT00425724","phase":"PHASE4","title":"HSP-glomerulonephritis Trial: MP vs CyA","status":"COMPLETED","sponsor":"Oulu University Hospital","startDate":"2000-01","conditions":"Purpura, Schoenlein-Henoch","enrollment":20},{"nctId":"NCT01205984","phase":"PHASE4","title":"Systemic Methylprednisolone in Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","startDate":"2007-07","conditions":"Chronic Rhinosinusitis, Children","enrollment":48},{"nctId":"NCT00554710","phase":"PHASE4","title":"Top Down Versus Step Up Strategies in Crohn's Disease","status":"COMPLETED","sponsor":"Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW","startDate":"2001-05","conditions":"Crohn's Disease","enrollment":129},{"nctId":"NCT00396747","phase":"PHASE4","title":"A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study","status":"COMPLETED","sponsor":"Université Catholique de Louvain","startDate":"2003-06","conditions":"Rheumatoid Arthritis","enrollment":45}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1297,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["MP"],"phase":"marketed","status":"active","brandName":"Methylprednisolone (MP)","genericName":"Methylprednisolone (MP)","companyName":"Masonic Cancer Center, University of Minnesota","companyId":"masonic-cancer-center-university-of-minnesota","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylprednisolone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production. Used for Acute graft-versus-host disease (GVHD) prophylaxis and treatment in hematopoietic stem cell transplantation, Autoimmune and inflammatory disorders (lupus, rheumatoid arthritis, vasculitis), Lymphomas and leukemias (as part of combination chemotherapy regimens).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}